Ninety One (UK)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-719,034
Closed -$75M 325
2017
Q4
$75M Sell
719,034
-1,230,170
-63% -$139M 0.31% 82
2017
Q3
$284M Buy
1,949,204
+390,475
+25% +$53.2M 1.25% 21
2017
Q2
$202M Sell
1,558,729
-4,317
-0.3% -$529K 0.96% 36
2017
Q1
$194M Buy
+1,563,046
New +$187M 0.96% 35

Other funds holding CELG

Ninety One (UK)'s CELG Position: Q1 2018 in Review

Ninety One (UK) sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 719,034 shares — an estimated $75M sold.

Ninety One (UK) first reported a position in CELG in Q1 2017 and held it in 4 quarters. The position peaked at $284M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Ninety One (UK) reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Ninety One (UK) sold 719,034 Celgene Corp shares in Q1 2018, an estimated $75M.
  • Ninety One (UK) first reported a position in Celgene Corp in Q1 2017 and held it in 4 quarters.
  • Ninety One (UK)'s Celgene Corp position peaked at $284M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Ninety One (UK)'s 13F filing for Q1 2018, filed 14 May 2018.